Switching immunoglobulin base therapy to nucleoside/nucleotide analogues monotherapy is safe and effective as preventive therapy of reccurent HBV in liver transplanted patients- single centre experience
Sneh, O., Cohen-Naftaly, M., Harif, Y., Issachar, A., Mor, E., Tur-Kaspa, R., Brown, M.Volume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(18)31249-2
Date:
April, 2018
File:
PDF, 51 KB
english, 2018